<DOC>
	<DOCNO>NCT00003721</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase I trial study effectiveness COL-3 treating patient advance solid tumor .</brief_summary>
	<brief_title>Chemotherapy Treating Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Define maximum tolerate dose COL-3 patient advance solid tumor . II . Identify dose limit toxicity safety profile COL-3 patient . III . Define pharmacokinetics pharmacodynamics COL-3 patient . IV . Observe evidence antitumor activity standard response criterion biologic surrogate marker . OUTLINE : This dose escalation study . Patients receive oral COL-3 daily . Treatment continue absence disease progression unacceptable toxic effect . Cohorts 3-6 patient receive escalate dos COL-3 . Dose escalation next level occur 3 patient complete 28 day treatment without dose limit toxicity ( DLT ) . Dose escalation continue maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 6 patient experience DLT . PROJECTED ACCRUAL : Up 30 patient accrue within 1 year study .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytopathologically proven advanced solid tumor conventional therapy exist refractory standard therapy No primary brain tumor active brain metastasis , include know evidence cerebral edema CT MRI , know tumor progression prior image study clinical symptom of/from brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Greater 12 week Hematopoietic : Absolute neutrophil count great 1,500/mm3 Platelet count great 100,000/mm3 Hemoglobin great 9 g/dL Hepatic : Bilirubin normal PT PTT normal ALT AST less 2.5 time upper limit normal Renal : Creatinine le 1.5 mg/dL OR Creatinine clearance great 60 mL/min Cardiovascular : No myocardial infarction , stroke , congestive heart failure within 3 month Other : HIV negative Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No history gastrointestinal disorder interfere absorption COL3 No active infection medical illnesses No psychological social problem No emotional disorder substance abuse No hypersensitivity tetracycline derivative PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since chemotherapy At least 6 week since nitrosoureas mitomycin At least 3 month since suramin Endocrine therapy : No concurrent steroids Radiotherapy : At least 4 week since prior large field radiation therapy ( great 20 % total bone marrow ) Surgery : At least 14 day since major surgery No major upper gastrointestinal surgery Other : No concurrent anticonvulsant medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>